-
Recent Posts
Top Rated
Most Popular:
- The Discovery of RG1678 (Gly-T1 inhibitor)
- PoseView
- Review: Gamma-secretase modulators
- Structure-based design of BACE inhibitors
- Review: Optimizing CNS access
- MDM2-p53 protein-protein interaction inhibitors
- Improving Solubility using X-ray crystal structure data
- Review: Chemical carcinogenicity and mutagenicity
- Discovery of PF-04691502 (PI3K/mTOR dual inhibitor)
- Review: Bioisosteres in Drug Design
Blogroll
Conferences
Intellectual Property
Journals
MedChem Resources
News
Organic Chemistry Resources
- Abbott
- adverse events
- allosteric
- allosteric inhibitor
- amine basicity
- Analgesic
- animal PK
- anti-viral
- AstraZeneca
- Aurora
- beta-secretase
- bioactivation
- BIRB-796
- Boehringer Ingelheim
- cancer
- cardiotoxicity
- cellular potency
- CGRP
- chloro
- CNS penetration
- computational method
- crystal packing
- CYP450
- Deuterium
- Doramapimod
- FAAH
- Fatty acid amide hydrolase
- fluorine
- free drug
- functional antagonist
- Gly-T1
- gpcr
- hepatotoxicity
- hERG
- immunosuppressant
- isostere
- kinase
- kinetic isotope effect
- Lexicon Pharmaceuticals
- LipE
- Merck
- metabolism
- mTOR
- nitrile
- Novartis
- osteoarthritis
- P-gp
- p38
- Pain
- PF-04457845
- PF-3845
- Pfizer
- Phase I
- Phase II
- Phase III
- POC
- PPB
- protein binding
- PSA
- reactive metabolite
- review
- RG1678
- rheumatoid arthritis
- Roche
- S1P1
- S1PL
- Schizophrenia
- solubility
- Structural alert
- Structure Based Design
- switch pocket
- synthesis
- toxicity
- Transporters
- X-ray data
Categories
Tag Archives: CGRP
Discovery of MK-2918 (CGRP Antagonist)
The triptan drugs have been highly successful in the treatment of migraine, but adverse effects and low responder rates in some patients have provided the impetus to develop alternative therapies. Blockers of the calcitonin gene-related peptide (CGRP) receptor have … Continue reading
Posted in GPCR ligands
Tagged ALT, CGRP, hERG, isostere, Merck, migraine, MK-0974, MK-2918, MK-3207, telcagepant, triptan
Leave a comment
Working with Ion Channels
Two recent publications highlight the challenges inherent in the targeting of voltage-gated and ion-gated ion channels. It is only in relatively recent times that technological advances (e.g. higher throughput patch-clamping) have opened up many of these targets to drug discovery … Continue reading
